The Egyptian Journal of Radiology and Nuclear Medicine (Sep 2023)

Long-term follow-up of CT-guided percutaneous radiofrequency ablation of T1 renal cell carcinoma

  • Mohamed Elsayed Ahmed Abdou Fouda,
  • Mahitab Mohamed Rashad Ghoneim,
  • Magdy Elsayed Mohamed Settein,
  • Mohamed Salah Ibrahim Tantawy,
  • Tarek Abdelmoneim El-Diasty

DOI
https://doi.org/10.1186/s43055-023-01100-2
Journal volume & issue
Vol. 54, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Background Radiofrequency ablation (RFA) has an established role in effective treatment of renal cell carcinomas (RCCs), as most of RCCs are diagnosed incidentally in early stages. Long-term follow-up is however important to consolidate the technique. Most of the literature contains series of short-term follow-ups of periods shorter than 2 years. This study in hand demonstrates the results of longer-term follow-up than the previously published series. Results Data analysis of 31 patient records involved in this study demonstrated the high clinical efficacy of RFA for long term, 12-year follow-up, by following the absence of tumor recurrences, as shown on regular interval contrast enhanced computed tomography (CT) and or magnetic resonance imaging (MRI). Conclusions RFA continues to prove its competent role in treating RCCs on longer-term follow-ups; the smaller the size of a tumor and the more peripheral the tumor is, the more effective the therapy. Even in larger early stages tumors, repeating the ablative sessions results in complete ablation without the need for more invasive surgical interventions.

Keywords